- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Profitable Climbers
Taiwanese Pharmaceuticals & Biotech Profitable Climbers
Results
3
0 new
3 companies
Bora Pharmaceuticals
Market Cap: NT$66.6b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$537.00
7D
-1.8%
1Y
-19.9%
PharmaEssentia
Market Cap: NT$221.9b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$600.00
7D
2.2%
1Y
-3.1%
Lotus Pharmaceutical
Market Cap: NT$84.7b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$322.00
7D
-4.6%
1Y
24.8%